Back to trial detailsIntake questionnaire
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Applying to Sarah Cannon Research Institute · Nashville, Tennessee
Answer a few short questions to share with the research team.
0 of 3 answered